These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 18049332
1. Generation of a tumor-specific systemic response after intratumoral injection of IL-12 and IL-18-loaded polylactic acid microspheres. Sabel MS, Arora A, Su G, Griffith KA, Mathiowitz E, Reineke JJ, Chang AE. J Immunother; 2007; 30(8):808-16. PubMed ID: 18049332 [Abstract] [Full Text] [Related]
2. Neoadjuvant intratumoral cytokine-loaded microspheres are superior to postoperative autologous cellular vaccines in generating systemic anti-tumor immunity. Arora A, Su G, Mathiowitz E, Reineke J, Chang AE, Sabel MS. J Surg Oncol; 2006 Oct 01; 94(5):403-12. PubMed ID: 16967445 [Abstract] [Full Text] [Related]
3. Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer. Sabel MS, Su G, Griffith KA, Chang AE. Breast Cancer Res Treat; 2010 Jul 01; 122(2):325-36. PubMed ID: 19802695 [Abstract] [Full Text] [Related]
4. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells. Sabel MS, Arora A, Su G, Mathiowitz E, Reineke JJ, Chang AE. Surgery; 2007 Nov 01; 142(5):749-60. PubMed ID: 17981196 [Abstract] [Full Text] [Related]
5. Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity. Sabel MS, Skitzki J, Stoolman L, Egilmez NK, Mathiowitz E, Bailey N, Chang WJ, Chang AE. Ann Surg Oncol; 2004 Feb 01; 11(2):147-56. PubMed ID: 14761917 [Abstract] [Full Text] [Related]
6. Neoadjuvant therapy with interleukin-12-loaded polylactic acid microspheres reduces local recurrence and distant metastases. Sabel MS, Hill H, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK. Surgery; 2001 Sep 01; 130(3):470-8. PubMed ID: 11562672 [Abstract] [Full Text] [Related]
7. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Hill HC, Conway TF, Sabel MS, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK. Cancer Res; 2002 Dec 15; 62(24):7254-63. PubMed ID: 12499267 [Abstract] [Full Text] [Related]
8. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation. Xu D, Gu P, Pan PY, Li Q, Sato AI, Chen SH. Int J Cancer; 2004 Apr 20; 109(4):499-506. PubMed ID: 14991570 [Abstract] [Full Text] [Related]
9. Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer. Oshikawa K, Rakhmilevich AL, Shi F, Sondel PM, Yang N, Mahvi DM. Hum Gene Ther; 2001 Jan 20; 12(2):149-60. PubMed ID: 11177552 [Abstract] [Full Text] [Related]
10. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes. Søndergaard H, Galsgaard ED, Bartholomaeussen M, Straten PT, Odum N, Skak K. J Immunother; 2010 Apr 20; 33(3):236-49. PubMed ID: 20445344 [Abstract] [Full Text] [Related]
11. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents. Kuhn S, Hyde EJ, Yang J, Rich FJ, Harper JL, Kirman JR, Ronchese F. J Immunol; 2013 Aug 15; 191(4):1984-92. PubMed ID: 23858033 [Abstract] [Full Text] [Related]
12. Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response. Pan J, Zhang M, Wang J, Wang Q, Xia D, Sun W, Zhang L, Yu H, Cao X. J Cancer Res Clin Oncol; 2005 Jul 15; 131(7):468-78. PubMed ID: 15711825 [Abstract] [Full Text] [Related]
13. Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth. Chaudhry UI, Kingham TP, Plitas G, Katz SC, Raab JR, DeMatteo RP. Cancer Res; 2006 Nov 01; 66(21):10497-504. PubMed ID: 17079471 [Abstract] [Full Text] [Related]
14. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor. van Herpen CM, van der Laak JA, de Vries IJ, van Krieken JH, de Wilde PC, Balvers MG, Adema GJ, De Mulder PH. Clin Cancer Res; 2005 Mar 01; 11(5):1899-909. PubMed ID: 15756016 [Abstract] [Full Text] [Related]
15. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells. Wei H, Zheng X, Lou D, Zhang L, Zhang R, Sun R, Tian Z. Mol Immunol; 2005 May 01; 42(9):1023-31. PubMed ID: 15829292 [Abstract] [Full Text] [Related]
16. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H. J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432 [Abstract] [Full Text] [Related]
17. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination. Tan C, Dannull J, Nair SK, Ding E, Tyler DS, Pruitt SK, Lee WT. J Surg Res; 2013 Dec 15; 185(2):904-11. PubMed ID: 23891424 [Abstract] [Full Text] [Related]
18. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo. Hughes DP, Baskar D, Urban FF, Friedman MS, Braun TM, McDonagh KT. Cytotherapy; 2005 Dec 15; 7(5):396-407. PubMed ID: 16236629 [Abstract] [Full Text] [Related]
19. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity. Ju DW, Yang Y, Tao Q, Song WG, He L, Chen G, Gu S, Ting CC, Cao X. Gene Ther; 2000 Oct 15; 7(19):1672-9. PubMed ID: 11083476 [Abstract] [Full Text] [Related]
20. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases. Lavi G, Voronov E, Dinarello CA, Apte RN, Cohen S. J Control Release; 2007 Nov 06; 123(2):123-30. PubMed ID: 17900737 [Abstract] [Full Text] [Related] Page: [Next] [New Search]